Peripheral blood molecular measurable residual disease is sufficient to identify patients with acute myeloid leukaemia with imminent clinical relapse

2021 ◽  
Author(s):  
Anne‐Sofie Skou ◽  
Kristian Løvvik Juul‐Dam ◽  
Hans B. Ommen ◽  
Henrik Hasle
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Peripheral Blood ◽  
Residual Disease ◽  
Clinical Relapse ◽  
Measurable Residual Disease ◽  
Acute Myeloid

scholarly journals Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia

2020 ◽  
Vol 190 (2) ◽  
pp. 198-208
Author(s):  
Kristian Løvvik Juul‐Dam ◽  
Hans B. Ommen ◽  
Charlotte G. Nyvold ◽  
Christiane Walter ◽  
Helen Vålerhaugen ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Peripheral Blood ◽  
Disease Surveillance ◽  
Residual Disease ◽  
Disease Assessment ◽  
Measurable Residual Disease ◽  
Acute Myeloid

Measurable residual disease testing in acute myeloid leukaemia

Leukemia ◽  
2017 ◽  
Vol 31 (7) ◽  
pp. 1482-1490 ◽  
Author(s):  
C S Hourigan ◽  
R P Gale ◽  
N J Gormley ◽  
G J Ossenkoppele ◽  
R B Walter
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Residual Disease ◽  
Measurable Residual Disease ◽  
Acute Myeloid ◽  
Disease Testing
Sign in / Sign up

Export Citation Format

Share Document